article thumbnail

Side Effects are Limiting GLP-1 Drug Efficacy: How Can Personalization Offer a Solution?

MedCity News

By integrating digitization and machine learning, there is an opportunity to deliver personalized care to all patients and scale precision dosing with minimal physician involvement, maximizing the effectiveness and accessibility of these drugs. appeared first on MedCity News.

article thumbnail

HCPs use of digital

World of DTC Marketing

The value proposition to HCP marketers is different from the value proposition that physicians want. They need to use the power of online to connect physicians and share information. When I worked on an Oncology drug, we included a forum where physicians could post questions to thought leaders on the drug.

article thumbnail

There are instances when TV (DTC) is NOT a good idea

World of DTC Marketing

OPENING: TV is great at creating awareness, but it can also scare patients away if one of your side effects is “may lead to death.” ” I understand that DTC marketers are in love with TV even though it’s becoming less effective. .” On top of these side effects is the common side effect of diarrhea.

article thumbnail

DTC as part of an integrated strategy

World of DTC Marketing

The research showed that patients wanted to understand how the drug works and the potential side effects. Patients who experienced side one or more side effects were more likely to delay or stop treatment. Most physicians are trained in medicine and rely on their experiences to understand patients.

article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

They research the drug online and ask their physician about it if they decide it’s a treatment option. 3hree: DTC marketing minimizes the side effects of prescription drugs – One of the top pages within prescription drug websites continues to be “safety information.” Again this is not true.

Marketing 285
article thumbnail

Is it too late for Biogen?

World of DTC Marketing

Never mind that physicians have turned against the drug Biogen wants to fight the decision because of their business needs. ” A physician on STAT News wrote, “the consequences of FDA approval are as disturbing as they are vast. The question that has to be asked is how will physicians respond to this drug if approved?

article thumbnail

Can pharma really leverage social media?

World of DTC Marketing

According to MedData Group, 72% of physicians surveyed were active on Facebook weekly, and 38% were active on Instagram and LinkedIn weekly. The types of professional content on Facebook that physicians are most likely to engage with include continuing medical education opportunities (37%) and physician online community information (31%).

Media 238